X

See our webpage about the GA-map® product platform

Visit page

Skip to content

Home
About us
Products
- Service Products
  - The GA-map® Dysbiosis Test Lx
  - The GA-map® COVID-19 Fecal Test Kit
- Lab Products
  - The GA-map® Dysbiosis Lx reagent kit
  - The GA-map® COVID-19 reagent kit
News
- Press Releases
- News
For Investors
Order
Contact us

Home
About us
Products
- Service Products
  - The GA-map® Dysbiosis Test Lx
  - The GA-map® COVID-19 Fecal Test Kit
- Lab Products
  - The GA-map® Dysbiosis Lx reagent kit
  - The GA-map® COVID-19 reagent kit
News
- Press Releases
- News
For Investors
Order
Contact us

Eilert Aamodt

Genetic Analysis AS receives preliminary approval for listing and publishes prospectus in connection with planned IPO

2021-09-222021-08-24

Genetic Analysis AS releases Interim report January – June 2021

2021-09-222021-08-20

Post navigation

Newer posts

← Previous Page1 … Page10 Page11

Genetic Analysis AS is providing a CE-marked gut microbiota analysis for testing bacterial imbalance in IBS and IBD patients.

Contact

Phone: +47 48 32 16 10
E-mail: info@genetic-analysis.com
Address: Genetic Analysis AS, Ulvenveien 80B
0581 Oslo, Norway

Open Google Maps

Connect

Navigate

© 2023 Genetic Analysis

Home
About us
Products
- Service Products
  - The GA-map® Dysbiosis Test Lx
  - The GA-map® COVID-19 Fecal Test Kit
- Lab Products
  - The GA-map® Dysbiosis Lx reagent kit
  - The GA-map® COVID-19 reagent kit
News
- Press Releases
- News
For Investors
Order
Contact us